Analysed Marker Therapeutics Inc (MRKR:NASDAQ) News Sources
Fulcrum Therapeutics Announces Positive 12-Week Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
Yahoo Finance UK
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
Yahoo Finance UK
HotSpot Therapeutics Presents Preclinical Data from Small Molecule IRF5 Inhibitor Program at 15th European Lupus Meeting
The Malaysian Reserve
Denali Therapeutics Inc. (DNLI) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Seeking Alpha
DiaMedica Therapeutics Receives Health Canada Clearance to Initiate Phase 2 Study of DM199 in Preeclampsia
Yahoo Finance
United Therapeutics' drug slows progression of rare lung condition in late-stage study
Reuters on MSN
What is the current price of Marker Therapeutics Inc (MRKR:NASDAQ)?
The current price of Marker Therapeutics Inc (MRKR:NASDAQ) is $1.38.
Marker Therapeutics Inc (MRKR:NASDAQ) absolute price change since previous trading day?
The absolute price change of Marker Therapeutics Inc (MRKR:NASDAQ) since the previous trading day is $-0.01.
Marker Therapeutics Inc (MRKR:NASDAQ) percentage price change since previous trading day?
The percentage price change of Marker Therapeutics Inc (MRKR:NASDAQ) since the previous trading day is -0.72%.
What is This Week's average sentiment score for Marker Therapeutics Inc (MRKR:NASDAQ)?
This Week's average sentiment score for Marker Therapeutics Inc (MRKR:NASDAQ) is 73 out of 100.
What is This Week's average sentiment for Marker Therapeutics Inc (MRKR:NASDAQ)?
This Week's sentiment for Marker Therapeutics Inc (MRKR:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.